Literature DB >> 8947971

Drug-induced pure red cell aplasia.

D F Thompson1, M A Gales.   

Abstract

Pure red cell aplasia (PRCA) is an uncommon hematologic disorder characterized by the absence of erythroblasts in otherwise normal bone marrow. It is commonly an autoimmune disorder sometimes associated with a congenital error. It may also be acquired in association with thymomas, hematologic malignancies, human parvovirus B19 infection, drugs, and other disease states. Thirty drugs have been implicated as causative in PRCA, but most literature reports describe only one or two patients. Data evaluating possible mechanisms of drug-induced PRCA are extremely limited, with conflicting results from different investigators. The criteria we used were at least five patients reported, reports from at least three separate investigators, and a minimum of one case of probable causality or better using a published assessment scale. With these criteria, phenytoin, azathioprine, and isoniazid had sufficient evidence of causality. All three are documented causes of PRCA and should be considered in any case of selective erythrocyte aplasia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8947971

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  13 in total

Review 1.  Anemia of Central Origin.

Authors:  Kazusa Ishii; Neal S Young
Journal:  Semin Hematol       Date:  2015-07-09       Impact factor: 3.851

Review 2.  A review of immunologic diseases of the dog.

Authors:  N C Pedersen
Journal:  Vet Immunol Immunopathol       Date:  1999-08-02       Impact factor: 2.046

Review 3.  Pure red cell aplasia.

Authors:  Robert T Means
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

4.  Successful treatment of acquired pure red cell aplasia with oral corticosteroids in a patient with B-cell CLL.

Authors:  Pramila Dharmshaktu; Naresh Gupta; Dinesh Kumar Dhanwal
Journal:  BMJ Case Rep       Date:  2013-11-14

5.  The haemotoxicity of azathioprine in repeat dose studies in the female CD-1 mouse.

Authors:  Gemma Molyneux; Frances M Gibson; Christabelle M Chen; Harpal K Marway; Sean McKeag; Charles V J Mifsud; Andrew M Pilling; Matthew J Whayman; John A Turton
Journal:  Int J Exp Pathol       Date:  2008-04       Impact factor: 1.925

6.  Tuberculosis in a patient on temozolomide: a case report.

Authors:  Tadeu Ferreira de Paiva; Milton José de Barros e Silva; José Augusto Rinck; Marcello Ferreti Fanelli; Daniel Luiz Gimenes
Journal:  J Neurooncol       Date:  2008-11-01       Impact factor: 4.130

7.  Lenalidomide-induced pure red cell aplasia.

Authors:  Tuphan Kanti Dolai; Shyamali Dutta; Prakas Kumar Mandal; Sandeep Saha; Maitreyee Bhattacharyya
Journal:  Turk J Haematol       Date:  2014-03-05       Impact factor: 1.831

8.  Isoniazid-induced Pure Red Cell Aplasia in a Patient with Sarcoidosis: A Patient Summary and Review of the Literature.

Authors:  Yasuyuki Saito; Yuri Sawada; Yasuhiko Koga; Noriaki Sunaga; Yusuke Tsukagoshi; Yoshimasa Hachisu; Takashi Osaki; Reiko Sakurai; Kyoichi Kaira; Akihiro Ono; Ken Sato; Hiromi Koiso; Tetsunari Oyama; Takeshi Hisada; Masanobu Yamada
Journal:  Intern Med       Date:  2017-09-15       Impact factor: 1.271

9.  Pure red cell aplasia associated with parvovirus B19 infection in a patient with ulcerative colitis.

Authors:  Hajime Isomoto; Yasuhiro Fukuda; Yumiko Bando; Ikuko Machida; Haruhisa Machida; Katsuhisa Omagari; Yohei Mizuta; Kunihiko Murase; Takuya Fukushima; Ikuo Murata; Shigeru Kohno
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.487

10.  Rational management approach to pure red cell aplasia.

Authors:  Suresh Kumar Balasubramanian; Meena Sadaps; Swapna Thota; Mai Aly; Bartlomiej P Przychodzen; Cassandra M Hirsch; Valeria Visconte; Tomas Radivoyevitch; Jaroslaw P Maciejewski
Journal:  Haematologica       Date:  2017-12-07       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.